Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07422935

Plant-Protein Dominant Tube Feed Study

Plant-Protein Dominant Tube Feed Study — Recruiting • Non-phase study • Gastroenterology • NCT07422935.

📅 21 Aug 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07422935
Start
2026-01-01
Completion
2028-07
ClinicaliQ Trial Snapshot
  • Plant-Protein Dominant Tube Feed Study — Recruiting • Non-phase study • Gastroenterology • NCT07422935.
  • Plant-based tube feeds tested against animal-based feeds for home patients over 12 months, measuring tolerance, compliance, and physical outcomes.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study aims to determine whether a reformulated plant-protein dominant protein blend in four existing enteral tube feeds is as effective as animal-protein dominant formulations in patients who are tube fed at home. This is an exploratory randomised, controlled, trial with a 3-day baseline period. Adult home tube feeding patients will be randomised to receive either a plant-protein dominant formulation or a control product (an animal-protein dominant formulation) for a 3-month intervention period followed by a 6-month and 12-month follow-up. The outcomes include gastrointestinal tolerance, compliance, acceptability, anthropometry, nutrient intake,…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Ex-situ machine perfusion devices to preserve deceased donor livers for transplantation
Gastroenterology · 20 Aug 2026
Consider ex-situ machine perfusion as an alternative to static cold storage for deceased donor livers, particularly for higher-risk grafts (extended criteria donors,…
View guideline →
Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →
Clinical Brief
1 in 4 births in England now by emergency C-section
Gastroenterology · BBC Health · 05 Jun 2026
Emergency caesarean section rate in England has risen to 25% of all births, representing a marked increase over the past five years…
View brief →
Clinical Brief
Islanders’ lifestyle views could help shape future
Gastroenterology · BBC Health · 14 Jun 2026
Island populations demonstrate distinct lifestyle patterns and health behaviours that warrant consideration in NHS service planning and public health policy development Understanding…
View brief →
Guideline
Hepatitis B (Chronic): Diagnosis and Management (NICE NG133)
Gastroenterology · 27 Mar 2026
Assess all newly diagnosed chronic hepatitis B patients with HBsAg, anti-HBc, HBeAg, anti-HBe, quantitative HBV DNA, ALT, and liver function tests before…
View guideline →
Guideline
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Gastroenterology · 27 Mar 2026
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use…
View guideline →